Articles

The European Heart Rhythm Association: A Myriad of Benefits and Privileges

Citation:

Arrhythmia & Electrophysiology Review 2016;5(2):82

Antiarrhythmic Drug Therapy to Avoid ICD Shocks

Citation:

Arrhythmia & Electrophysiology Review 2016;5(2):117–21

Individualising Anticoagulant Therapy in Atrial Fibrillation Patients

Citation:

Arrhythmia & Electrophysiology Review 2016;5(2):102–9

The European Heart Rhythm Association: On the Move Towards the Future of Electrophysiology

Citation:

Arrhythmia & Electrophysiology Review 2016;5(1):10-1

Consensus Document on Supraventricular Arrhythmias: A Valuable Initiative from EHRA

Citation:

Arrhythmia & Electrophysiology Review 2016;5(1):8

Atrioventricular Nodal Reentrant Tachycardia

Citation:

Arrhythmia & Electrophysiology Review 2016;5(2):130–5

Significance of Shocks in Implantable Cardioverter Defibrillator Recipients

Citation:

Arrhythmia & Electrophysiology Review 2016;5(2):110–6

Anatomical Substrates and Ablation of Reentrant Atrial and Ventricular Tachycardias in Repaired Congenital Heart Disease

Citation:

Arrhythmia & Electrophysiology Review 2016;5(2):150–60

Reducing Fluoroscopy Time and Radiation Dosage During AF Ablation

Citation:

Arrhythmia & Electrophysiology Review 2016;5(2):144–9

Controversy Surrounding ROCKET-AF: A Call for Transparency, But Should We Be Changing Practice?

Citation:

Arrhythmia & Electrophysiology Review 2016;5(1):12–3